Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Roche’s ENSPRYNG Approved by European Commission as First and Only At-home Subcutaneous Treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved […]
Kite Announces Yescarta® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma
Kite, a Gilead Company (Nasdaq: GILD), today announced top-line results from the primary analysis of […]
New Soliqua ® Data Shows Improved Blood Sugar Control Without Weight Gain Versus Premixed Insulin
A new study of Soliqua (insulin glargine 100 Units/mL and lixisenatide, iGlarLixi) met its two […]
WHO and ECDC Launch Indicator Framework to Evaluate Public Health Effectiveness of Digital Proximity Tracing Solutions
The European Centre for Disease Prevention and Control (ECDC) together with WHO, through its headquarters […]
NHS Launches Online Service to Find Nearest Walk-in Jab Site
The NHS COVID-19 Vaccination programme, the biggest in health service history, today launched a new […]
Rt Hon Sajid Javid MP Appointed Secretary of State for Health and Social Care
The Queen has been pleased to approve the appointment of the Rt Hon Sajid Javid […]
New Class of Compounds Found to Block Coronavirus Reproduction
A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help […]
eTheRNA and VUB to Engineer Next Generation mRNA Therapeutics with TetraMix ®
eTheRNA immunotherapies NV (‘eTheRNA’, Niel, Belgium), a clinical-stage company developing mRNA-based immunotherapies for the treatment of […]
NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions
NuvoAir – the digital health company on a mission to improve the lives of millions […]
Artificial Intelligence Breast Cancer Screening Project Wins Government Funding for NHS Trial
UK researchers have secured government funding to study the use of artificial intelligence (AI) for breast cancer screening in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more